» Articles » PMID: 34182608

Contributions of the International Plant Science Community to the Fight Against Human Infectious Diseases - Part 1: Epidemic and Pandemic Diseases

Abstract

Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ˜17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world.

Citing Articles

Impact of Gene Knockout on Cell Aggregation in Suspension Culture.

Frankevich T, Permyakova N, Sidorchuk Y, Deineko E BioTech (Basel). 2025; 14(1.

PMID: 39846551 PMC: 11755664. DOI: 10.3390/biotech14010002.


Anti-Inflammatory Effects of Helminth-Derived Products: Potential Applications and Challenges in Diabetes Mellitus Management.

Zhu Y, Chen X, Zheng H, Ma Q, Chen K, Li H J Inflamm Res. 2025; 17:11789-11812.

PMID: 39749005 PMC: 11694023. DOI: 10.2147/JIR.S493374.


A time series study of the association between extreme temperature and ozone on varicella incidence.

Zhang J, Wang B, Li Z, Zhang W, Yan S, Geng Q Sci Rep. 2024; 14(1):31187.

PMID: 39732810 PMC: 11682333. DOI: 10.1038/s41598-024-82306-w.


Biotechnological Interventions for the Production of Subunit Vaccines Against Group A Rotavirus.

Prajapati M, Malik P, Sinha A, Yadav H, Jaiwal Y, Ahlawat Y Cell Biochem Funct. 2024; 42(8):e70031.

PMID: 39707603 PMC: 11662099. DOI: 10.1002/cbf.70031.


Production of Plant Virus-Derived Hybrid Nanoparticles Decorated with Different Nanobodies.

Lozano-Sanchez E, Daros J, Merwaiss F ACS Nano. 2024; 18(50):33890-33906.

PMID: 39622501 PMC: 11656832. DOI: 10.1021/acsnano.4c07066.


References
1.
Li H, Chye M . Use of GFP to investigate expression of plant-derived vaccines. Methods Mol Biol. 2009; 515:275-85. PMC: 7120478. DOI: 10.1007/978-1-59745-559-6_19. View

2.
Schillberg S, Raven N, Spiegel H, Rasche S, Buntru M . Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins. Front Plant Sci. 2019; 10:720. PMC: 6579924. DOI: 10.3389/fpls.2019.00720. View

3.
Ceballo Y, Tiel K, Lopez A, Cabrera G, Perez M, Ramos O . High accumulation in tobacco seeds of hemagglutinin antigen from avian (H5N1) influenza. Transgenic Res. 2017; 26(6):775-789. DOI: 10.1007/s11248-017-0047-9. View

4.
Margolin E, Chapman R, Meyers A, van Diepen M, Ximba P, Hermanus T . Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens. Front Plant Sci. 2019; 10:1378. PMC: 6831737. DOI: 10.3389/fpls.2019.01378. View

5.
Buyel J, Fischer R . Predictive models for transient protein expression in tobacco (Nicotiana tabacum L.) can optimize process time, yield, and downstream costs. Biotechnol Bioeng. 2012; 109(10):2575-88. DOI: 10.1002/bit.24523. View